FDA approves IV antibacterial for complicated UTIs, abdominal infections

FDA approves IV antibacterial for complicated UTIs, abdominal infections A combination of a cephalosporin and a beta-lactamase inhibitor in an intravenous formulation has been approved for treating complicated intra-abdominal infections